Pregnancy-related venous thromboembolism.

D. Dizon-Townson
DOI: https://doi.org/10.1097/00003081-200206000-00007
2002-06-01
Abstract:Pulmonary embolism (PE), although rare, remains the leading cause of maternal death in Western countries. Furthermore, deep venous thrombosis (DVT) is a cause of significant maternal morbidity. The actual incidence of pregnancy-related venous thromboembolic (VTE) events during pregnancy is unknown. This is probably due in part to the issue of asymptomatic versus clinically symptomatic thrombosis. VTE is excluded in approximately 75% of patients who present with suspected disease and are then subjected to objective testing such as Doppler ultrasound or venography. When DVT has been diagnosed and medical therapy instituted, the incidence of PE and maternal death is significantly reduced. Due to the pregnancy-induced changes to the coagulation system, pregnancy is a hypercoagulable state and confers an increase risk for VTE. Certain inherent and environmental risk factors increase this risk. The goal of this review is to facilitate the recognition of the clinical signs and symptoms of VTE disorders, review the use of various diagnostic and treatment modalities, and describe a rational approach to the hypercoagulable workup.
What problem does this paper attempt to address?